SCREENING LIBRARIES Sample Clauses

SCREENING LIBRARIES. DiCE shall make available at least [*] Screening Libraries for screening in the Research Program. [*]. With respect to Active Sanofi Targets, the JSC shall determine which Screening Library [*] shall be used to screen against such Sanofi Target(s). In accordance with the applicable Target Plans agreed by the JSC, DiCE shall screen at least one Screening Library against each Active Sanofi Target for a minimum of [*] rounds (unless otherwise agreed by the JSC, or with regard to the applicable Sanofi Target, Sanofi selects it as an ES Target, or the JSC designates it as an ET Target). For purposes of this section “screen” shall mean the sequential selection rounds of DPDCE using the Screening Library or Focused Libraries with each Active Sanofi Target and its controls (ligands, etc) to determine if a positive selection [*] has occurred and suggesting the presence of Active Compounds in the Library. The Parties acknowledge that if screens on Active Sanofi Targets fail to identify Active Compounds then new Screening Libraries may be made, subject to the final decision of the JSC.

SCREENING LIBRARIES. 2.1 Upon INTRABIOTICS’ request, NCE shall supply to INTRABIOTICS one (1) aliquot, [ * ] of no less than the equivalent of [ * ] of the original [ * ] or [ * ] of each sample, [ * ] in the Screening Libraries, at NCE’s expense, in accordance with Appendix A. 2.2 INTRABIOTICS agrees that all right, title and interest in and to the Screening Libraries shall be vested in NCE. NCE shall be free to provide the Screening Libraries to third parties for screening purposes both inside and outside the Screening Field. 2.3 INTRABIOTICS agrees that the Screening Libraries: (i) will be maintained and used by INTRABIOTICS only at the sites designated in Appendix C; (ii) will not be transferred to any other location; (iii) will only be used by employees of INTRABIOTICS, or its permitted sublicensees and those consultants of INTRABIOTICS who agree to be bound by the terms and conditions of this Agreement including but not limited to this Section 2.3 listed in Appendix C, who will require access thereto for the performance of this Agreement; (iv) will only be used for screening against the Targets and for no other purpose, with such use permitted only during the [ * ] period following the date that the relevant Screening Library is received by INTRABIOTICS; (v) that INTRABIOTICS will not attempt to identify any of the components contained in the Screening Libraries except as expressly permitted in Section 2.5 with respect to [ * ]; and (vi) will not be transferred to any third party except in connection with a sublicense pursuant to Section 4.1. INTRABIOTICS may, in its sole discretion, amend Appendix B from time to time to add targets to the Target list. 2.4 In the event that INTRABIOTICS uses the Screening Libraries for any purpose not permitted under this Agreement, in addition to any other remedies NCE may have, NCE may cause INTRABIOTICS to (i) assign to NCE all right, title and interest to all intellectual property arising from such use (except to the extent such intellectual property would also cover a permitted use) and (ii) execute those documents as requested by NCE necessary to document and/or perfect the assignment of such intellectual property. 2.5 INTRABIOTICS shall have the right to conduct [ * ] studies of the samples contained in the Screening Libraries, solely in order to identify a [ * ] of such sample likely to demonstrate Activity. Such studies will not include attempts to identify the chemical structures of any components of any such [ * ]. INTRABIOTIC...